✦ LIBER ✦
A multicenter randomized phase II study of sequential epirubicin/cyclophosphamide followed by docetaxel with or without celecoxib or trastuzumab according to HER2 status, as primary chemotherapy for localized invasive breast cancer patients
✍ Scribed by Jean-Yves Pierga; Suzette Delaloge; Marc Espié; Etienne Brain; Brigitte Sigal-Zafrani; Marie-Christine Mathieu; Philippe Bertheau; Jean Marc Guinebretière; Marc Spielmann; Alexia Savignoni; Michel Marty
- Publisher
- Springer US
- Year
- 2010
- Tongue
- English
- Weight
- 236 KB
- Volume
- 122
- Category
- Article
- ISSN
- 0167-6806
No coin nor oath required. For personal study only.